Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care
NCT ID: NCT06148779
Last Updated: 2024-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50000 participants
OBSERVATIONAL
2022-01-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Education Program for Osteoarthritis With Exercise Included
NCT01119547
Patient Enablement in Osteoarthritis - a Longitudinal Study on Patient Education Programs in Primary Health Care
NCT02974036
Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment
NCT01071447
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
NCT01435109
Comparison of Tele-rehabilitation or Video-Based Core Exercises in Individuals With Axial Spondyloarthritis
NCT06000072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The first-line OA management program has been transformed into a digital version, Joint Academy® (JA), to facilitate implementation, scaling, increased accessibility, and improved patient adherence. The mobile application (app) consists of video instructions distributed daily with individualized exercises for participants with knee or hip OA, as well as educational information on OA symptoms and self-management based on current international guidelines for the management of OA. Each participant is assigned to a physical therapist available through asynchronous chat and telephone who supervises the participant throughout the whole program.
To improve chronically ill patients' health and quality of life, long-standing and continuous treatment is needed at an acceptable cost. Recent evidence suggests that JA costs 25% compared to the BOA program for three months of treatment. Providing patients with equal access to care necessitates availability in urban and rural areas alike. This can potentially be achieved by digital delivery, but it is yet unknown if digital delivery of first-line OA treatment, compared with face-to-face, improves equal access to care. The purpose of this study was to compare utilization of digital and face-to-face delivered OA treatment in the 21 different county councils of Sweden that are responsible for providing healthcare to the residents.
Method Registered patient participation in the BOA program during 2021-2023 will be retrieved from the BOA Register. The BOA registry. Data from digital program participation was retrieved from the JA database. To be included, a patient need to have registered for the first visit in the BOA registry or have enrolled in the program by answering the first questionnaire in the JA registry.
Population density per county and county size were retrieved from Statistics Sweden. Results were calculated and presented as users per 100 000 residents. Mean and median values as well as standard deviations were calculated separately for registered participants/100 000 for BOA and JA programs, and for regions with more (n=12) or less (n=8) than 20 residents per km2.
Please not that the BOA registry was in January 2023 renamed to The Swedish Osteoarthritis Registry.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Joint Academy
Digitally delivered first-line treatment for osteoarthritis
Digitally delivered first-line for osteoarthritis through the caregiver Joint Academy.
BOA
Face-to-face first-line treatment for osteoarthritis
First-line for osteoarthritis delivered at a primary care clinic face-to-face with reported data to the BOA registry.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digitally delivered first-line treatment for osteoarthritis
Digitally delivered first-line for osteoarthritis through the caregiver Joint Academy.
Face-to-face first-line treatment for osteoarthritis
First-line for osteoarthritis delivered at a primary care clinic face-to-face with reported data to the BOA registry.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* From October 1st 2021, all patients should have undergone a physical examination by doctor or physiotherapists before being able to enter the treatment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
The Swedish Osteoarthritis Registry
UNKNOWN
Joint Academy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leif E Dahlberg, Senior professor
Role: STUDY_DIRECTOR
Joint Academy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Joint Academy
Malmo, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Leif E Dahlberg, Senior Professor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Access to care OA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.